issued
on 27 Feb 2024
Last Applicant/ Owned by
140 First Street
Cambridge
MA
02141
Serial Number
98157840 filed on 30th Aug 2023
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculRead More
Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
No 98157840
No Service/Collective Mark
No V03222000701
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 27th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 02th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Dec 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 26th Dec 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 26th Dec 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 13th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 29th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Nov 2023 | ASSIGNED TO EXAMINER |
| 27th Sep 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
